Published October 24, 2022 | Version v1

Novel trehalose-based excipients for stabilizing nebulized anti-SARS-CoV-2 antibody

Description

Raw data associated to the study entitled "Novel trehalose-based excipients for stabilizing nebulized anti-SARS-CoV-2 antibody", including:

- Synthesis development: experimental procedures and characterization

- DLS data for CxxTreSuc excipients

- Cytotoxicity

Files

DLS Fig2+4.zip

Files (668.5 MB)

Name Size
md5:420aabf2fdc08ed0080b6aa22fab0647
113.2 kB Download
md5:1a3df996c64248ebf8ec36472aeb29ab
1.7 MB Preview Download
md5:c5068151c242e994864baac4dcd0644e
3.5 MB Preview Download
md5:410a9123a6abdc534b287e66020429c9
2.0 MB Preview Download
md5:30bb11109df9c60d81044e06f08f8396
4.4 MB Preview Download
md5:fa8a9089bdc18d0ca26fc6a6752d5663
168.6 kB Preview Download
md5:bed68b1d752ee122500e9023cad251be
656.6 MB Preview Download